Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy (Randomized Trial of BV Treatment in Pregnancy) View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

1999-2005

ABSTRACT

The goal of this study is to examine acceptability and efficacy of 2 kinds of BV treatment among women at low risk for preterm delivery. The objectives are: 1. To examine the side effects and patient acceptability of oral versus intravaginal metronidazole. 2. To compare the efficacy of oral and intravaginal metronidazole for the treatment of BV 3. To study the efficacy of oral and intravaginal metronidazole for the prevention of hospital admission during the 3rd trimester, chorioamnionitis, preterm delivery, and maternal infectious morbidity. Detailed Description This is a randomized, placebo-controlled intervention trial. Women diagnosed as BV+ by Gram stain at 12-16 weeks gestation are randomly assigned to the following treatment groups: oral metronidazole (250 mg TID x 7 days) with intravaginal placebo; intravaginal metronidazole (5g 0.75% gel BID x 5 days) with oral placebo. African American, Hispanic, Asian/Pacific Islander, Native American, and white women are eligible. Women with a prior preterm delivery, multiple gestation, chronic hypertension or pre-existing diabetes, antibiotic use before enrollment in the study, allergy to metronidazole, history of alcohol abuse in past year, and women under age 18 are excluded. More... »

URL

https://clinicaltrials.gov/show/NCT00153517

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3177", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "The goal of this study is to examine acceptability and efficacy of 2 kinds of BV treatment among women at low risk for preterm delivery. The objectives are: 1. To examine the side effects and patient acceptability of oral versus intravaginal metronidazole. 2. To compare the efficacy of oral and intravaginal metronidazole for the treatment of BV 3. To study the efficacy of oral and intravaginal metronidazole for the prevention of hospital admission during the 3rd trimester, chorioamnionitis, preterm delivery, and maternal infectious morbidity.\n\nDetailed Description\nThis is a randomized, placebo-controlled intervention trial. Women diagnosed as BV+ by Gram stain at 12-16 weeks gestation are randomly assigned to the following treatment groups: oral metronidazole (250 mg TID x 7 days) with intravaginal placebo; intravaginal metronidazole (5g 0.75% gel BID x 5 days) with oral placebo. African American, Hispanic, Asian/Pacific Islander, Native American, and white women are eligible. Women with a prior preterm delivery, multiple gestation, chronic hypertension or pre-existing diabetes, antibiotic use before enrollment in the study, allergy to metronidazole, history of alcohol abuse in past year, and women under age 18 are excluded.", 
    "endDate": "2005-03-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT00153517", 
    "keywords": [
      "maternal effect", 
      "bacterial vaginosis", 
      "pregnancy", 
      "acceptability", 
      "efficacy", 
      "woman", 
      "low risk", 
      "preterm delivery", 
      "side effect", 
      "patient acceptability", 
      "Metronidazole", 
      "prevention", 
      "hospital admission", 
      "trimester", 
      "chorioamnionitis", 
      "morbidity", 
      "intervention trial", 
      "Gram", 
      "treatment group", 
      "TID", 
      "placebo", 
      "gel", 
      "Asian/Pacific Islander", 
      "white woman", 
      "multiple gestation", 
      "chronic hypertension", 
      "diabetes", 
      "antibiotic use", 
      "enrollment", 
      "Hypersensitivity", 
      "history", 
      "Alcoholism", 
      "age 18"
    ], 
    "name": "Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy (Randomized Trial of BV Treatment in Pregnancy)", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT00153517"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00001.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.470962.e", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.34477.33", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.416738.f", 
        "type": "Organization"
      }
    ], 
    "startDate": "1999-10-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "sg:pub.10.1186/1471-2334-9-89", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029548136", 
          "https://doi.org/10.1186/1471-2334-9-89"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT00153517"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT00153517'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT00153517'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT00153517'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT00153517'


 

This table displays all metadata directly associated to this object as RDF triples.

60 TRIPLES      16 PREDICATES      51 URIs      42 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT00153517 schema:about anzsrc-for:3177
2 schema:description The goal of this study is to examine acceptability and efficacy of 2 kinds of BV treatment among women at low risk for preterm delivery. The objectives are: 1. To examine the side effects and patient acceptability of oral versus intravaginal metronidazole. 2. To compare the efficacy of oral and intravaginal metronidazole for the treatment of BV 3. To study the efficacy of oral and intravaginal metronidazole for the prevention of hospital admission during the 3rd trimester, chorioamnionitis, preterm delivery, and maternal infectious morbidity. Detailed Description This is a randomized, placebo-controlled intervention trial. Women diagnosed as BV+ by Gram stain at 12-16 weeks gestation are randomly assigned to the following treatment groups: oral metronidazole (250 mg TID x 7 days) with intravaginal placebo; intravaginal metronidazole (5g 0.75% gel BID x 5 days) with oral placebo. African American, Hispanic, Asian/Pacific Islander, Native American, and white women are eligible. Women with a prior preterm delivery, multiple gestation, chronic hypertension or pre-existing diabetes, antibiotic use before enrollment in the study, allergy to metronidazole, history of alcohol abuse in past year, and women under age 18 are excluded.
3 schema:endDate 2005-03-01T00:00:00Z
4 schema:keywords Alcoholism
5 Asian/Pacific Islander
6 Gram
7 Hypersensitivity
8 Metronidazole
9 TID
10 acceptability
11 age 18
12 antibiotic use
13 bacterial vaginosis
14 chorioamnionitis
15 chronic hypertension
16 diabetes
17 efficacy
18 enrollment
19 gel
20 history
21 hospital admission
22 intervention trial
23 low risk
24 maternal effect
25 morbidity
26 multiple gestation
27 patient acceptability
28 placebo
29 pregnancy
30 preterm delivery
31 prevention
32 side effect
33 treatment group
34 trimester
35 white woman
36 woman
37 schema:name Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy (Randomized Trial of BV Treatment in Pregnancy)
38 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT00153517
39 schema:sdDatePublished 2019-03-07T15:21
40 schema:sdLicense https://scigraph.springernature.com/explorer/license/
41 schema:sdPublisher Nb8559cb3a5c94b3da8b693956c80d4c8
42 schema:sponsor https://www.grid.ac/institutes/grid.34477.33
43 https://www.grid.ac/institutes/grid.416738.f
44 https://www.grid.ac/institutes/grid.470962.e
45 schema:startDate 1999-10-01T00:00:00Z
46 schema:subjectOf sg:pub.10.1186/1471-2334-9-89
47 schema:url https://clinicaltrials.gov/show/NCT00153517
48 sgo:license sg:explorer/license/
49 sgo:sdDataset clinical_trials
50 rdf:type schema:MedicalStudy
51 Nb8559cb3a5c94b3da8b693956c80d4c8 schema:name Springer Nature - SN SciGraph project
52 rdf:type schema:Organization
53 anzsrc-for:3177 schema:inDefinedTermSet anzsrc-for:
54 rdf:type schema:DefinedTerm
55 sg:pub.10.1186/1471-2334-9-89 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029548136
56 https://doi.org/10.1186/1471-2334-9-89
57 rdf:type schema:CreativeWork
58 https://www.grid.ac/institutes/grid.34477.33 schema:Organization
59 https://www.grid.ac/institutes/grid.416738.f schema:Organization
60 https://www.grid.ac/institutes/grid.470962.e schema:Organization
 




Preview window. Press ESC to close (or click here)


...